Please assess the completion status of the following clinical trial:

Trial Title: Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~1. healthy male subjects~Exclusion criteria:~1. Any relevant deviation from healthy conditions

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 1 Nintedanib (Reference) (Type: EXPERIMENTAL): single dose, oral with 240 ml water
- 2 Nintedanib + Ketoconazole (Test) (Type: EXPERIMENTAL): Nintedanib single dose, Ketoconazole steady state, oral with 240 ml water
- 3 Nintedanib (Reference) (Type: EXPERIMENTAL): single dose, oral with 240 ml water
- 4 Nintedanib + Ketoconazole (Test) (Type: EXPERIMENTAL): Nintedanib single dose, Ketoconazole steady state, oral with 240 ml water

Based on this trial design, predict the completion outcome and termination type (if applicable).